Kitazato Corporation (TYO:368A)

Market Cap	54.44B
Revenue (ttm)	10.98B +8.9%
Net Income	3.98B +0.3%
EPS	99.60 +0.3%
Shares Out	40.00M
PE Ratio	13.66
Forward PE	13.70
Dividend	41.00 (2.99%)
Ex-Dividend Date	Mar 30, 2026

Volume	85,500
Average Volume	104,595
Open	1,376.00
Previous Close	1,373.00
Day's Range	1,360.00 - 1,386.00
52-Week Range	1,295.00 - 2,158.00
Beta	n/a
RSI	50.52
Earnings Date	Apr 30, 2026

About Kitazato

Kitazato Corporation researches, develops, manufactures, and markets medical devices and related products for fertility treatment. It offers needles, catheters and cannulas, vitrification media and equipment, sperm processing medium/tools, IVF medium products, micro tools, and labware products. The company was formerly known as Kitazato Biopharma Co., Ltd. The company was founded in 1998 and is based in Shizuoka, Japan. Kitazato Corporation is a subsidiary of Kitasato Shoji Co., Ltd.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1998
• Employees: 86
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 368A

Financial Performance

In fiscal year 2025, Kitazato's revenue was 10.30 billion, an increase of 2.20% compared to the previous year's 10.08 billion. Earnings were 3.79 billion, a decrease of -4.63%.